Month: October 2021

Oct 20 2021

Uncategorized

Real-life social network in schizophrenia patients and individuals with social anhedonia

by Clinical Editor

No Comments

Schizophrenia is a complex brain disorder characterized by severe social dysfunctions. A similar but attenuated format of social dysfunction has also been found in individuals with subclinical …

Oct 20 2021

Uncategorized

Lybalvi now available for adults with schizophrenia, bipolar 1 disorder

by Clinical Editor

No Comments

Alkermes has announced that its schizophrenia/bipolar 1 disorder treatment Lybalvi is now available by prescription in the U.S.The once-daily, oral atypical antipsychotic treatment (olanzapine and …

Oct 19 2021

Uncategorized

A Racial Disparity in Schizophrenia Diagnoses in Nursing Homes

by Clinical Editor

No Comments

Diagnoses for the disorder have soared in the past decade, driven in part by a loophole in regulations. A new study shows the impact has been more severe for Black...

Oct 19 2021

Uncategorized

Can CBD Help Treat Symptoms of Schizophrenia?

by Clinical Editor

No Comments

Can CBD help treat schizophrenia? Read on to find out. There’s some human research on CBD and schizophrenia, but there isn’t enough evidence to conclude that CBD should be used...

Oct 19 2021

Uncategorized

Dysbindin-1 and schizophrenia: from genetics to neuropathology

by Clinical Editor

No Comments

The gene encoding dysbindin-1 has recently been implicated in susceptibility to schizophrenia. In this issue of the JCI, Talbot et al. show that, contrary to expectations, dysbindin-1 is located …

Oct 19 2021

Uncategorized

Implications of Genetic Findings for Understanding Schizophrenia

by Clinical Editor

No Comments

From the perspective of those of us working on the genetics of schizophrenia, recent progress in identifying specific genetic risk factors at highly robust levels of statistical significance has been...

Oct 19 2021

Uncategorized

Real-life social network in schizophrenia patients and individuals with social anhedonia

by Clinical Editor

No Comments

Schizophrenia is a complex brain disorder characterized by severe social dysfunctions. A similar but attenuated format of social dysfunction has also been found in individuals with subclinical …

Oct 18 2021

Uncategorized

Alkermes Announces Commercial Availability of LYBALVI® for the Treatment of Schizophrenia and Bipolar I Disorder

by Clinical Editor

No Comments

Alkermes plc (Nasdaq: ALKS) today announced that LYBALVI ® (olanzapine and samidorphan) is now available by prescription in the United States (U.S.) for the treatment of adults with schizophrenia, and...

Oct 18 2021

Uncategorized

Dysbindin-1 and schizophrenia: from genetics to neuropathology

by Clinical Editor

No Comments

The gene encoding dysbindin-1 has recently been implicated in susceptibility to schizophrenia. In this issue of the JCI, Talbot et al. show that, contrary to expectations, dysbindin-1 is located …

Oct 18 2021

Uncategorized

A Racial Disparity in Schizophrenia Diagnoses in Nursing Homes

by Clinical Editor

No Comments

Diagnoses for the disorder have soared in the past decade, driven in part by a loophole in regulations. A new study shows the impact has been more severe for Black...